Approximately seven percent of breast cancer cases are caused by mutations in the BRCA1 or BRCA2 genes.1 Individuals who carry a mutation in either the BRCA1 or BRCA2 gene have a condition called Hereditary Breast and Ovarian Cancer (HBOC) syndrome, which is associated with an 87 percent risk of developing breast cancer by age 70.2-4 Mutation carriers who have already been diagnosed with cancer also have a significantly increased risk of developing a second cancer. Myriad offers genetic testing that can be used to identify patients who are carriers of a BRCA1, BRCA2 or other gene mutation.
In order to assess your risk of carrying a BRCA1, BRCA2 or other gene mutation, your healthcare professional may ask you questions about your personal and family history. Knowing your medical history helps your healthcare professional determine whether you might be an appropriate candidate for genetic testing. Genetic testing can provide an accurate assessment of your risk of developing breast and/or ovarian cancer.
To help you determine whether you may benefit from genetic testing, take the Myriad Hereditary Cancer assessment. Answering a few questions can help give you the information you need to discuss your risk of cancer with your healthcare professional.
Take the Hereditary Cancer assessment
Knowing your potential risk for HBOC can help you and your healthcare professional make better, more informed decisions about your health, before the onset of cancer or before a second cancer has had a chance to develop. Genetic testing for hereditary breast and ovarian cancer with the Myriad Genetics MyRisk® Hereditary Cancer panel should be considered if:*
You:
Your Family
If the Myriad Genetics MyRisk® Hereditary Cancer Test confirms the presence of a BRCA1 or BRCA2 mutation or a mutation in another gene associated with breast cancer risk, the following medical management options may help reduce your risk and may either possibly prevent or possibly delay the onset of breast cancer or detect cancer at an earlier, more treatable stage:†
By using the results of Myriad Genetics MyRisk® Hereditary Cancer Test, your healthcare professional can help you move forward with the right action plan for your particular risk. Your test results can also help your family members learn and understand more about inherited cancer risk and how it may affect them.
*Assessment criteria are based on medical society guidelines.
**HBOC-associated cancers are breast, ovarian, prostate and pancreatic.
†Any discussion of medical management options is for general informational purposes only and does not constitute a recommendation. While genetic testing and medical society guidelines provide important and useful information, all medical management decisions should be made based on consultation between each patient and his or her healthcare professional.
1. Claus EB, et al. The genetic attributable risk of breast and ovarian cancer. Cancer 1996;77:2318-2324.
2. Pal T, et al. BRCA1 and BRCA2 mutations account for a large proportion of ovarian carcinoma cases. Cancer 2005;104(12):2807-2816.
3. Risch H, et al. Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer. Am J Hum Genet 2001: 68:700-710.
4. Ford D, et al. Risks of cancer in BRCA1-mutation carriers. Breast Cancer Linkage Consortium. Lancet. 1994 343:692-5. PMID: 7907678.
Note: You do not need to have a personal cancer diagnosis to qualify for testing.
Based on your answers so far, you may meet current medical guidelines for hereditary cancer testing. This means you might have an underlying risk for developing cancer and may want to consider genetic testing.
Why we ask: Our hereditary cancer tests require that you work with a healthcare provider. If you don’t have a provider or don’t think you’ll be seeing one soon, we have virtual care options that will connect you with a genetics professional online.
We know there’s a lot to consider when it comes to getting tested. To help you decide your next steps, sign up below and we’ll send you expert information about hereditary cancer testing from our team of genetic counselors.
Why we ask: Nine out of ten patients pay $0 for MyRisk testing through insurance. However, there may be out-of-pocket costs for those without insurance.
There may be out-of-pocket costs for those without insurance coverage. But we, at Myriad, are committed to providing affordable access to testing and comprehensive support for all appropriate patients and their families. Before you take the next step, talk to our Financial Access Team about your options.
Why we ask: Some insurance providers require additional steps for genetic testing, so knowing this information helps us get you on the best path to testing.
In order to take the next step, you’ll need to work with a healthcare provider to order the test and discuss your results. Since you have an existing provider, we recommend working with them for the best testing experience. Use the form below to have a DNA collection kit sent to you free of charge. Then, bring it to your provider to discuss testing and place your test order.
In order to take the next step, you’ll need to work with a healthcare provider to order the test and discuss your results.
We’ve partnered with Genome Medical’s nationwide network of clinical and genetic experts to provide care to you through the testing process for a $129 consult fee that may be covered by your insurance. Get started now, all from the comfort of your home.
In order to take the next step, you’ll need to work with a healthcare provider to order the test and discuss your results. We’ve partnered with Genome Medical’s nationwide network of clinical and genetic experts to provide care to you through the testing process for a $42 consult fee, all in the comfort of your home.
Testing is currently available to individuals 18 years of age and older.
If you’re concerned about your risk of developing cancer, you may want to consider speaking with your healthcare provider or a cancer genetics professional. To help you do that, we’ve partnered with Genome Medical’s nationwide network of leading clinical and genetic experts. (Consult fee is $42 and may be covered by your insurance.)
Sign up to receive the latest news and product updates from Myriad Genetics.
Quick — name three diseases that affect humans. We bet you came up with some of the most well-known, such as heart disease, cancer, Alzheimer’s, and COVID-19. Those are all extremely common, affe...